The demand for plasma-derived therapies is set to witness a significant increase, with the Plasma Fractionation Market Demand projected to reach USD 64.22 billion by 2035. The Plasma Fractionation Market Demand is being driven by robust growth in the immunology sector, which is anticipated to capture a 45% share by 2024, fueled by the rise in autoimmune disorders and related...
Portuguese 
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt